Skip to main content

Table 2 Demographic and clinical data

From: Retrospective agreement and consent to neurocritical care is influenced by functional outcome

 

All

Ischemia

ICH

SAH

Meningoencephalitis

Epilepsy

GBS/MG

Neurodeg./

Enceph.

Cerebral neoplasm

Intox.

n (%)

704

241 (34.2)

205 (29.1)

37 (5.3)

47 (67)

86 (12.2)

24 (3.4)

20 (2.8)

19 (2.7)

25 (3.6)

Age (median, range)

67 (18-95)

72 (21-93)

70 (35-95)

56 (19-84)

63 (27-85)

59 (18-93)

58 (23-78)

66 (23-85)

65 (39-78)

53 (29-78)

Female sex (n, %)

328 (46.6)

107 (44.4)

95 (46.3)

19 (51.4)

24 (51.1)

42 (48.8)

13 (54.2)

13 (65.0)

7 (36.8)

8 (32.0)

Mechanical ventilation (n, %)

447 (63.5)

143 (59.3)

141 (68.8)

20 (54.1)

40 (85.1)

44 (51.2)

15 (62.5)

17 (85.0)

7 (36.8)

20 (80.0)

Preadmission

mRS 0-2 (n, %)

628 (89.2)

226 (93.7)

180 (87.8)

34 (91.9)

42 (89.4)

63 (73.3)

23 (95.8)

9 (45.0)

6 (31.6)

45 (96.0)

Consent of all patients (n, %)

361 (51.3)

98 (40.7)

76 (37.1)

23 (62.1)

38 (80.9)

62 (72.1)

19 (79.2)

11 (55.0)

14 (73.7)

20 (80.0)

Satisfaction (n, %)

643 (91.3)

224 (92.9)

195 (95.1)

35 (94.6)

45 (95.7)

65 (75.6)

22 (91.7)

18 (90.0)

16 (84.2)

23 (92.0)

  1. Demographic and clinical characteristics as well as overall consent and satisfaction of all patients (n = 704) separated for diagnoses.
  2. ICH, Intracranial hemorrhage; SAH, subarachnoid hemorrhage; GBS, Guillain-Barré syndrome; MG, myasthenia gravis; Neurodeg, neurodegenerative disease; Enceph, encephalopathy; Intox, intoxication; n, number; mRS, modified Rankin Scale.